Deal with CSPC Pharmaceutical comes three months after China’s state medical insurance, which covers more than 95% of the nation’s 1.4 billion people, stopped reimbursing Paxlovid

Coronavirus vaccines and treatments fueled the drug giant’s global revenue surge to over $100 billion last year while other products stagnated

Amid a pandemic buying frenzy and surging black market prices, Chinese distributors point fingers at manufacturers of generic drugs in India

A failure in this year’s price negotiations with the government will leave the Covid drug uncovered by the national program after March 31

The wave of infections raging across the country has led to a rush on common drugs such as ibuprofen, but supplies remain scant, at least for now

As Covid cases climb, the State Council has allowed medical institutions to do online prescribing of drugs used to treat Covid-related symptoms

CPSC Pharmaceutical moves to test its own Covid pill while conducting trials of ingredients for a generic version of Pfizer’s Paxlovid

World’s most widely used mRNA vaccine languishes unapproved in China as Fosun Pharma and BioNTech see window of opportunity closing

Local manufacture of Pfizer’s anti-Covid pill to boost domestic availability; Paxlovid faces competition from cheaper homegrown treatment, Genuine Biotech’s Azvudine

Scientists try to invent a broad-spectrum inoculation for future mutations while racing to fortify today’s shots against omicron subvariants

There’s a long way to go in rolling out the advanced shots for China as Western companies control patents and Chinese companies face technological barriers

China’s playbook of lockdowns, mass testing and quarantines can’t keep up with BA.2 variant as city experiences shortages of food and medical care

Amid worst Covid-19 outbreak, city could turn pandemic into manageable endemic disease using self-isolation, self-testing and advanced drugs and vaccines

Amid its worst outbreak, city could turn pandemic into manageable endemic disease using self-isolation, self-testing and advanced drugs and vaccines

UN-backed group designates Desano, Huahai, Apeloa, Fosun and Jiuzhou among 35 companies to make low-cost versions of Pfizer’s Covid pill for poorer countries

The first batch of 75 Chinese mainland medical personnel has also arrived in Hong Kong to boost the city’s capacity to treat severe cases amid the worst local outbreak

China Meheco links up with Pfizer to market Paxlovid. The country sends the first batch of humanitarian aid to Ukraine

State-owned drugmaker signs 2022 supply contract to commercialize Paxlovid as the first foreign treatment approved in China

China’s creating a financial security fund. Refined oil prices in the nation soar to near 10-year highs

State-owned drugmaker’s shares surge by 10% limit on four straight days in Shanghai, though its role may be limited to distribution logistics